Forecyte Bio Limited
7495 New Horizon Way, Suite 130-150, Frederick，MD 21703
Tel.: +1 215-589-3593
177 Yiwei Road, Pilot free trade zone, Shanghai, China
Tel.：+86 21 80438700
Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions.
On November 6, 2022, Forecyte Bio, a trusted one-stop CDMO provider in the field of cell& gene therapy (CGT), and Thermo Fisher Scientific, a global leader in enabling technical advancement, signed and entered into a strategic cooperation agreement on the first day of the China International Import Expo.
On November 10, The 24th Shanghai International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum 2022) series｜China Biotechnology and Pharmaceutical Innovation Forum and 2022 China Biopharmaceutical Technology Innovation Value List Award was held in Shanghai, initiated by Shanghai Biopharmaceutics Industry Association (SBIA). Forecyte Bio was listed in the "Top 10 Most Innovative and Growing CXO Companies" in China.
In 2022, the Cell & Gene Meeting on the Mesa (MOTM) organized by the Alliance for Regenerative Medicine (ARM) was held in Carlsbad, California. It attracted many participants worldwide and witnessed the tremendous growth of the cell and gene therapy (CGT) industry.
As the largest cooperation activity and trade exhibition in Asia and one of the most historic biotechnology exhibitions in the world, Asia‘s Premier Hybrid Partnering Event brought three theme exhibitions in Yokohama, Japan, from October 12 to 14 in the golden autumn: The world's oldest biotechnology exhibition "BioJapan" (1986-), "Regenerative Medicine JAPAN" (2016-), aiming to accelerate and industrialize R&D in the field of regenerative medicine including iPS cells, and "health TECH JAPAN"(2020-), provides a fusion of digital technology and life science. Numerous pharmaceutical and biotechnology enterprises, research institutions, and universities have gathered to actively communicate with each other to accelerate global opening and industrial innovation.